The Challenge You Face
- Complex market access and reimbursement pathways across PBS, MBS and Prescribed List
- Uncertainty around clinical, economic and value evidence requirements
- Evolving PBAC, MSAC and MDHTAC expectations and increasing scrutiny
How Pulse Economics Solves It
- Faster progression to funding on the PBS, MBS and Prescribed List with fewer avoidable rework cycles
- Clinical, economic and pricing evidence built to withstand HTA and payer scrutiny
- Decision-ready market access strategies aligned to PBAC, MSAC and MDHTAC
- End-to-end submission support from strategy through to acceptance
WE PROVIDE
Evidence Strategy & Generation
Design and support clinical and real-world evidence strategies that directly address HTA, payer and policy requirements.
Market Access & Reimbursement
Guide clients through the complexities of PBS, MBS and Prescribed List pathways, helping products progress efficiently from evidence generation to reimbursement and patient access.
Commercialisation & Growth Strategy
Help clients, including early-stage ventures, develop a strong commercialisation strategy, supporting growth and effective life cycle management.
Modelling & Data Analytics
Perform robust statistical, financial and economic modelling that withstand HTA and payer scrutiny.
Health Policy
Support government, research organisations and industry in shaping health policy initiatives.
ORGANISATIONS WE’VE WORKED WITH
LATEST NEWS & INSIGHTS
Explore how we can support you